Risk of impairment of investment securities due to declining excess earning power at unlisted investees
First written in FY2025. 2 of 4 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2023: 6 of 13 companies on the "Worse" side.
6 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「During the consolidated fiscal year under review, impairment losses were recognized on shares of affiliated companies of ¥19,871 thousand and securities of affiliated companies of ¥320,180 thousand.」
The risk materialized, with impairment losses totaling ¥340,051 thousand recognized on shares and securities of affiliated companies. The Group also recognized an equity-method investment loss of ¥317,514 thousand related to RemoteLock, Inc. and other investments. - 2026-08-22RestatedGeneral Meetings of Shareholders
「If the fair value of shares, reflecting the evaluation of the investee’s excess earning power, falls to approximately 50% or less of their acquisition cost, an impairment loss is recognized.」
Restates the valuation method for unlisted shares and the impairment assessment criteria, with future sales forecasts and the discount rate as the principal assumptions. - FY2026-H1RestatedAnnual report
「During the six months ended 30 September 2024, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous consolidated fiscal year.」
The Group disclosed in aggregate that there had been no material change from the previous fiscal year in the risk of impairment of investment securities from a decline in the excess earning power of unlisted investees. - FY2025First statedAnnual report
「If the fair value of shares, reflecting the evaluation of the investee’s excess earning power, falls to approximately 50% or less of their acquisition cost, an impairment loss is recognized.」
For shares without a market price, the Group assesses value using the investee’s business plan, projected future sales and discount rate and discloses the impairment risk when actual value falls to approximately 50% or less of acquisition cost.